Pulmonary Embolism 2016
Avatar

Novel Anticoagulants (NOACs): The Data in Standard and High-Risk Patients...Which ones When? Are These Now First-line Therapy?

By Pulmonary Embolism 2016 FEATURING Rachel Rosovsky
By Pulmonary Embolism 2016 FEATURING Rachel Rosovsky
0 views
October 17, 2016
Comments 1
Login to view comments. Click here to Login

Recommended

AUTOPLAY
19:49
Rush University Medical Center

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Feat. S. Jain
14:59
PERT Consortium 2021

New European Guidelines on Pulmonary Embolism: What Has Changed and …

Feat. S. Konstantinides
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
05:31
Pulmonary Embolism 2016

Pulmonary Embolism During Pregnancy

Feat. J. Bartholomew
13:25
TCT 2022 Conference Coverage

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

Feat. W. Jaber
16:11
Jeffrey Weitz

Extended Anticoagulation for VTE

10:12
Pulmonary Embolism Symposium (PERT 2017)

Long Term Anticoagulation - How and For How Long?

11:39
Mount Sinai Endovascular Fellows Course

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Feat. J. Giri
08:01
PERT Consortium 2022

Update on HI-PEITHO - A Landmark Clinical Trial in PE

Feat. K. Rosenfield
16:54
NYU Langone

Management of Acute Pulmonary Embolism: How Long Do You Treat?

Feat. N. Amoroso
44:26
The North American Thrombosis Forum (NATF)

Panel Discussion: Acute vs Chronic Changes in PE, Anticoagulation Du…

Feat. G. Piazza, J. Rodriguez-Lopez, B. Bikdeli, A. Witkin, F. Rahaghi, A. Wong
05:30
PERT Consortium 2021

Triaging Acute Pulmonary Embolism for Home Treatment or Simplified P…

Feat. M. Huisman
16:51
PERT Consortium 2021

Pathobiology and Medical Management of CTEPH: Panel Discussion

Feat. B. Rivera-Lebron, S. Bartolome, E. Klok, A. Witkin, T. Todoran
13:33
PERT Consortium 2021

PE in the Ambulatory and Hospital Settings: Scope of the Problem

Feat. G. Barnes
24:16
ARCH Advanced Revascularization Symposium

Q&A: Thrombus Management

Feat. K. Rosenfield, S. Mathews, A. G. El-Shafei
14:53
William Peacock

MERCURY-PE Trial: Does the Outpatient Treatment with Rivaroxaban Dec…

13:18
NY Endovascular Summit

Medical Management of PE

Feat. J. Goldfinger
23:27
UPMC

Treatment of Pulmonary Embolism

Feat. B. Schwartz
20:27
University of Miami

PE Interventions: Patient and Device Selection

Feat. S. Afanador
13:50
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Systematic Approach to Pulmonary Embolism Management

Feat. J. Paul